
Avizen Biopharma Private Limited
Pharmaceutical company specializing in drugs, healthcare, and surgical products.
Pharmaceutical company specializing in drugs, healthcare, and surgical products.
Avizen Biopharma Private Limited (ABPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 August 2016 (Eight years and six months 26 days old ). Its registered office is in Kamrup, Assam, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.22 Cr.
The company currently has active open charges totaling ₹3.66 Cr.
Mahendra Verma, Rajendra Verma, and Sunil Khemani serve as directors at the Company.
Kamrup, Assam, India
+91-XXXXXXXXXX
-
U24304AS2016PTC017532
017532
Private Limited Indian Non-Government Company
09 Aug 2016
30 Sep 2024
31 Mar 2024
Unlisted
Roc Shillong
Name | Designation | Appointment Date | Status |
---|---|---|---|
Mahendra Verma ![]() | Director | 09-Aug-2016 | Current |
Rajendra Verma ![]() | Director | 09-Aug-2016 | Current |
Sunil Khemani ![]() | Director | 25-Feb-2017 | Current |
Avizen Biopharma Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 43.52% increase. The company also saw a substantial improvement in profitability, with a 55.49% increase in profit. The company's net worth observed a substantial decline by a decrease of 84.43%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2024, Avizen Biopharma had a promoter holding of 76.32% and a public holding of 23.68%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Mahendra Verma and Rajendra Verma are mutual person
Rajendra Verma is a mutual person
Rajendra Verma is a mutual person
Rajendra Verma is a mutual person
₹3.66 Cr
₹0
Date | Lender | Amount | Status |
---|---|---|---|
04 Dec 2021 | Others | ₹1.85 M | Open |
29 Sep 2020 | Others | ₹3.68 M | Open |
30 Mar 2017 | Others | ₹3.11 Cr | Open |
Avizen Biopharma has a workforce of 13 employees as of Feb 17, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Avizen Biopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avizen Biopharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Avizen Biopharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Avizen Biopharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Shillong.
A charge with Others amounted to Rs. 0.19 Cr with Charge ID 100516420 was registered on 04 Dec 2021.
A charge with Others of Rs. 3.11 Cr registered on 30 Mar 2017 with Charge ID 100094089 was modified on 28 Jul 2021.
A charge with Others amounted to Rs. 0.37 Cr with Charge ID 100397271 was registered on 29 Sep 2020.
A charge with Others amounted to Rs. 3.11 Cr with Charge ID 100094089 was registered on 30 Mar 2017.
Avizen Biopharma Private Limited was incorporated on 09 Aug 2016.
The authorized share capital of Avizen Biopharma Private Limited is ₹ 5.00 Cr and paid-up capital is ₹ 4.22 Cr.
Currently 3 directors are associated with Avizen Biopharma Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Avizen Biopharma Private Limited is Sagar Bizz Plex 1St Floor S.R. Bora Lane G.S. Road, Ulubari India, Guwahati, Assam, 781007.
The corporate identification number (CIN) of Avizen Biopharma Private Limited is U24304AS2016PTC017532 and the company number is 017532 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2024, the revenue trend for Avizen Biopharma Private Limited has risen by 43.52%.
As Per 2024 financial reports, 13 employees are currently employed by Avizen Biopharma Private Limited.
The financial reports for the fiscal year 2024 indicates that The net worth of Avizen Biopharma Private Limited has experienced an downturn of -84.43%.
As per the financial statements for fiscal Year 2024, The total open charges for Avizen Biopharma Private Limited amount to ₹ 3.66 Cr.
The most recent Balance Sheet for Avizen Biopharma Private Limited was filed with the ROC on 31 Mar 2024.
SS